Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

42 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of Cilastatin on Cisplatin-Induced Nephrotoxicity in Patients Undergoing Hyperthermic Intraperitoneal Chemotherapy.
Zaballos M, Power M, Canal-Alonso MI, González-Nicolás MÁ, Vasquez-Jimenez W, Lozano-Lominchar P, Cabrerizo-Torrente P, Palencia-García N, Gago-Quiroga S, Ginel-Feito MD, Jiménez C, Lázaro A, González-Bayón L. Zaballos M, et al. Among authors: gonzalez bayon l. Int J Mol Sci. 2021 Jan 27;22(3):1239. doi: 10.3390/ijms22031239. Int J Mol Sci. 2021. PMID: 33513824 Free PMC article.
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for the treatment of advanced epithelial ovarian carcinoma: upfront therapy, at first recurrence, or later?
Gonzalez Bayon L, Steiner MA, Vasquez Jimenez W, Asencio JM, Alvarez de Sierra P, Atahualpa Arenas F, Rodriguez del Campo J, Garcia Sabrido JL. Gonzalez Bayon L, et al. Eur J Surg Oncol. 2013 Oct;39(10):1109-15. doi: 10.1016/j.ejso.2013.06.022. Epub 2013 Jul 17. Eur J Surg Oncol. 2013. PMID: 23870278
Morbidity and mortality outcomes after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in patients aged 75 years and over: Spanish group of peritoneal cancer surgery (GECOP) multicenter study.
Cascales-Campos PA, López-López V, Muñoz-Casares FC, Feliciangeli E, Torres Melero J, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Gil J. Cascales-Campos PA, et al. Surg Oncol. 2016 Jun;25(2):111-6. doi: 10.1016/j.suronc.2016.03.007. Epub 2016 Apr 4. Surg Oncol. 2016. PMID: 27312037
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei and appendix tumours in elderly patients: Is it justified?
López-López V, Cascales-Campos PA, Gil E, Arevalo J, Gonzalez A, Gil J, Muñoz-Casares FC, Melero JT, Barrios P, Morales R, Ramos I, Ortega G, Camps B, González-Bayón L, Bretcha-Boix P, Farré-Alegre J, González-Moreno S, Parrilla P. López-López V, et al. Clin Transl Oncol. 2017 Nov;19(11):1388-1392. doi: 10.1007/s12094-017-1728-9. Epub 2017 Aug 10. Clin Transl Oncol. 2017. PMID: 28812240
Survival outcomes in patients aged 75 years and over with peritoneal colorectal carcinomatosis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (HIPEC): multicenter study of the Spanish Group of Peritoneal Cancer Surgery (GECOP).
Cascales-Campos PA, López-López V, Torres-Melero J, Arjona A, Muñoz-Casares FC, Barrios P, Morales R, Pereira F, Bretcha-Boix P, González-Bayón L, González-Moreno S, Gil J. Cascales-Campos PA, et al. Clin Transl Oncol. 2020 Jan;22(1):130-136. doi: 10.1007/s12094-019-02124-9. Epub 2019 May 2. Clin Transl Oncol. 2020. PMID: 31049819
GECOP-MMC: phase IV randomized clinical trial to evaluate the efficacy of hyperthermic intraperitoneal chemotherapy (HIPEC) with mytomicin-C after complete surgical cytoreduction in patients with colon cancer peritoneal metastases.
Pereira F, Serrano A, Manzanedo I, Pérez-Viejo E, González-Moreno S, González-Bayón L, Arjona-Sánchez A, Torres J, Ramos I, Barrios ME, Cascales P, Morales R, Boldó E, García-Fadrique A, Arteaga X, Gutierrez-Calvo A, Sánchez-García S, Asensio E, Ramírez CP, Artiles M, Vaqué J, Parra PA, Villarejo P, Muñoz-Casares C, Turienzo E, Calero A, Torrejimeno IJ, Prieto I, Galindo J, Borrego V, Marcello ME, Rihuete C, Carrasco J, Gomez-Quiles L. Pereira F, et al. Among authors: gonzalez bayon l. BMC Cancer. 2022 May 12;22(1):536. doi: 10.1186/s12885-022-09572-7. BMC Cancer. 2022. PMID: 35549912 Free PMC article. Clinical Trial.
ASO Author Reflections: Predicting Prognosis in Patients with Pseudomyxoma.
Martín Román L, Lozano Lominchar P, Baratti D, Vásquez W, González Bayón L. Martín Román L, et al. Among authors: gonzalez bayon l. Ann Surg Oncol. 2022 Nov;29(12):7564-7565. doi: 10.1245/s10434-022-12287-5. Epub 2022 Jul 27. Ann Surg Oncol. 2022. PMID: 35896919 No abstract available.
42 results